Systemic radiation is injected radiation that circulates through the body to target metastasis. There are several types of systemic radiation all of which have been shown to prolong life with limited side effects. This episode covers current systemic radiation options as well as exciting, new advancements on the horizon. If you have advanced prostate cancer,
Immunotherapy trains the patient’s own immune system to target and attack cancer cells. For men with prostate cancer immunotherapy can provide long-term efficacy with minimal side effects. This episode explores the innovations in immunotherapy including the use of off-label therapy and the promise of combination therapy. Don’t miss out on these new and exciting capabilities
Hormone therapy, or Testosterone Inactivating Pharmaceuticals, work to either stop testosterone’s production or limit testosterone’s activity in promoting prostate cancer growth. These powerful anti-cancer drugs can put men with prostate cancer in remission for years and in some cases even decades! Discover hormone therapy treatment protocol and monitoring, get insight to hormone resistance, and learn
Gleason 6 prostate cancer may sound like a dangerous type of prostate cancer. Luckily that is not the case, Gleason 6 prostate cancer does not spread. This means men with Gleason 6 can be safely monitored through active surveillance and avoid the side effects that come with treatment.
Active surveillance is not synonymous with watchful waiting, and it no longer means periodic random biopsy. Learn the active surveillance protocol and discover a Gleason 6 lifestyle.
Radical prostatectomy is one of the most popular treatments for prostate cancer. Surgery is broadcasted all over the media as the gold standard of prostate cancer treatment. But does surgery really live up to the hype?
This episode of PROSTATE PROS covers the “Just Cut it Out!” mentality, the surgery versus radiation debate, and the side effects of the radical prostatectomy.
PROSTATE PROS invites Alex Scholz, CEO of the Prostate Cancer Research Institute (PCRI), to discuss how the PCRI helps educate men and caregivers. Scholz gives us a look inside the PCRI’s annual and mid-year patient conferences, the PCRI helpline, and all the ways they provide free, expert-reviewed information on all aspects of prostate cancer. ABOUT